NCT07042919 2025-06-29
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Northwestern University
Phase 1/2 Not yet recruiting
Clinical Trials
5 trialsNCT05586516 2025-03-20
A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic Cancer
iOnctura
Phase 1/2 Active not recruiting
NCT02273362 2024-03-26
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT01429038 2022-06-14
Mesenchymal Stem Cells After Renal or Liver Transplantation
University of Liege
Phase 1/2 Completed
NCT01264705 2020-11-12
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed